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Chronic pain is classified as nociceptive or neuropathic,
depending on whether the integrity of the somatosensory
nervous system is compromised by the underlying disease.
Nociceptive pain results from the activation of receptors
(nociceptors) sensitive to noxious stimuli. Prolonged or
intense exposure to these stimuli, for example, chemical
mediators released during inflammation, enhances the
responsiveness of nociceptive nerve fibers [1]. This pro-
cess, termed peripheral sensitization, involves a shift in the
activation threshold of nociceptors and upregulation of
voltage-gated sodium channels. Peripheral sensitization
leads to increased action potential firing and transmitter
release in the dorsal horn of the spinal cord, where soma-
tosensory information is processed. Dorsal horn neurons
react to the rising input with heightened excitability, a
process termed central sensitization. Enhanced depolariza-
tion leads to the recruitment of N-methyl-D-aspartate
(NMDA)-type glutamate receptors. NMDA and neuropep-
tide receptor activation produces a sharp increase in intra-
cellular calcium, triggering signaling pathways and gene
expression changes that promote a long-term shift in the
activity of nociceptive circuits [2]. In some aspects, central
sensitization even resembles long-term potentiation of
excitatory transmission in the hippocampus. Central sensi-
tization generates an exaggerated response to painful sti-
muli (hyperalgesia) and contributes to pain elicited by
normally nonpainful stimuli (allodynia). Clinical findings
suggest that pain hypersensitivity produces structural
changes in the brain over time. These changes are, how-
ever, reversible upon pain relief. The pathophysiology of
neuropathic pain is fundamentally different. Peripheral
nerve lesion evokes stimulus-independent (ectopic) activity
in nerve fibers. Innate immune cells react at the lesion site,
in the dorsal root ganglion, where the cell bodies of per-
ipheral somatosensory neurons reside, and in the dorsal
horn of the spinal cord [3]. Active microglia of the dorsal
horn releases chemical mediators that modulate the activ-
ity of neurons in the vicinity. One of these mediators,
brain-derived neurotrophic factor, reduces the inhibitory
effect of g-aminobutyric acid (GABA) and glycine. Disinhi-
bition opens polysynaptic connections in the dorsal horn,
further enhancing the abnormal input from the lesioned
nerve. Similarly to nociceptive pain, central sensitization
occurs. Worsened by a relative deficit in transmitter
uptake, increased glutamatergic transmission causes exci-
totoxic cell death, reducing the number of inhibitory inter-
neurons. Their loss and a shift in descending modulatory
pathways from the brainstem produce a profound imbal-
ance between inhibition and excitation. The complexity of
chronic pain mechanisms poses a major therapeutic chal-
lenge. Without biomarkers, it will remain difficult to
develop targeted strategies for chronic pain reduction or
prevention in the individual patient.
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